These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19834407)

  • 1. Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage.
    Momin EN; Schwab KE; Chaichana KL; Miller-Lotan R; Levy AP; Tamargo RJ
    Neurosurgery; 2009 Nov; 65(5):937-45; discussion 945. PubMed ID: 19834407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage.
    Pradilla G; Garzon-Muvdi T; Ruzevick JJ; Bender M; Edwards L; Momin EN; Thompson RC; Tamargo RJ
    Neurosurgery; 2012 Mar; 70(3):747-56; discussion 756-7. PubMed ID: 21915076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release of lipopolysaccharide in the subarachnoid space of rabbits induces chronic vasospasm in the absence of blood.
    Recinos PF; Pradilla G; Thai QA; Perez M; Hdeib AM; Tamargo RJ
    Surg Neurol; 2006 Nov; 66(5):463-9; discussion 469. PubMed ID: 17084186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats.
    Gabikian P; Clatterbuck RE; Eberhart CG; Tyler BM; Tierney TS; Tamargo RJ
    Stroke; 2002 Nov; 33(11):2681-6. PubMed ID: 12411661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits.
    Pradilla G; Thai QA; Legnani FG; Hsu W; Kretzer RM; Wang PP; Tamargo RJ
    Neurosurgery; 2004 Dec; 55(6):1393-9; discussion 1399-1400. PubMed ID: 15574221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage.
    Frazier JL; Pradilla G; Wang PP; Tamargo RJ
    J Neurosurg; 2004 Jul; 101(1):93-8. PubMed ID: 15255257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm.
    McGirt MJ; Pradilla G; Legnani FG; Thai QA; Recinos PF; Tamargo RJ; Clatterbuck RE
    Neurosurgery; 2006 May; 58(5):945-51; discussion 945-51. PubMed ID: 16639331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice can be prevented with a glutathione peroxidase mimetic.
    Froehler MT; Kooshkabadi A; Miller-Lotan R; Blum S; Sher S; Levy A; Tamargo RJ
    J Clin Neurosci; 2010 Sep; 17(9):1169-72. PubMed ID: 20541941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.
    Atalay B; Caner H; Cekinmez M; Ozen O; Celasun B; Altinors N
    Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial delivery of the nitric oxide donor diethylenetriamine/nitric oxide from a controlled-release polymer: toxicity in cynomolgus monkeys.
    Tierney TS; Pradilla G; Wang PP; Clatterbuck RE; Tamargo RJ
    Neurosurgery; 2006 May; 58(5):952-60; discussion 952-60. PubMed ID: 16639332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local delivery of ibuprofen via controlled-release polymers prevents angiographic vasospasm in a monkey model of subarachnoid hemorrhage.
    Pradilla G; Thai QA; Legnani FG; Clatterbuck RE; Gailloud P; Murphy KP; Tamargo RJ
    Neurosurgery; 2005 Jul; 57(1 Suppl):184-90; discussion 184-90. PubMed ID: 15987587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage.
    Chaichana KL; Levy AP; Miller-Lotan R; Shakur S; Tamargo RJ
    Stroke; 2007 Dec; 38(12):3266-71. PubMed ID: 17962599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and reversal of experimental posthemorrhagic vasospasm by the periadventitial administration of nitric oxide from a controlled-release polymer.
    Tierney TS; Clatterbuck RE; Lawson C; Thai QA; Rhines LD; Tamargo RJ
    Neurosurgery; 2001 Oct; 49(4):945-51; discussion 951-3. PubMed ID: 11564257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm.
    Lin CL; Dumont AS; Calisaneller T; Kwan AL; Hwong SL; Lee KS
    Surg Neurol; 2005 Sep; 64(3):201-5; discussion 205-6. PubMed ID: 16099244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-methoxyestradiol reduces cerebral vasospasm after 48 hours of experimental subarachnoid hemorrhage in rats.
    Yan J; Chen C; Lei J; Yang L; Wang K; Liu J; Zhou C
    Exp Neurol; 2006 Dec; 202(2):348-56. PubMed ID: 16904108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].
    Garzon-Muvdi T; Pradilla G; Ruzevick JJ; Bender M; Edwards L; Grossman R; Zhao M; Rudek MA; Riggins G; Levy A; Tamargo RJ
    Neurosurgery; 2013 Oct; 73(4):719-28; discussion 729. PubMed ID: 23842553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of cerebral vasospasm by local delivery of cromakalim with a biodegradable controlled-release system in a rat model of subarachnoid hemorrhage.
    Omeis I; Chen W; Jhanwar-Uniyal M; Rozental R; Murali R; Abrahams JM
    J Neurosurg; 2009 May; 110(5):1015-20. PubMed ID: 19119878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leflunomide prevents vasospasm secondary to subarachnoid haemorrhage.
    Belen D; Besalti O; Yiğitkanli K; Kösemehmetoğlu K; Simşek S; Bolay H
    Acta Neurochir (Wien); 2007 Oct; 149(10):1041-7; discussion 1047-8. PubMed ID: 17876498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates.
    Clatterbuck RE; Gailloud P; Tierney T; Clatterbuck VM; Murphy KJ; Tamargo RJ
    J Neurosurg; 2005 Oct; 103(4):745-51. PubMed ID: 16266059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adenosine 2A receptor agonist ATL-146e attenuates experimental posthemorrhagic vasospasm.
    Chang CZ; Dumont AS; Simsek S; Titus BJ; Kwan AL; Kassell NF; Solenski NJ
    Neurosurgery; 2007 Jun; 60(6):1110-7; discussion 1117-8. PubMed ID: 17538386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.